ArticleTherapeutic advances in medical oncology2026

Metabolic marker profiling of circulating tumour cells in NSCLC patients treated with osimertinib: focus on MCT1 and MCT4.

Karolina Mangani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.